2011;58:409 17. S10.4-7. Wong MC, Kalman JM, Pedagogos E, et al. Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol. 2015;65:1263 5. S10.4-8. Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e392 e414. S10.4-9. Pun PH, Hellkamp AS, Sanders GD, et al. Primary prevention implantable cardioverter defibrillators in end-stage kidney dis- ease patients on dialysis: a matched cohort study. Nephrol Dial Transplant. 2015;30:829 35. 10.5. Valvular Heart Disease S10.6-1. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521 643. S10.6-2. Genereux P, Stone GW, O Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptom- atic severe aortic stenosis. J Am Coll Cardiol. 2016;67:2263 88. S10.6-3. Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106:1355 61. S10.6-4. Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078 85. S10.6-5. Nordhues BD, Siontis KC, Scott CG, et al. Bileaflet mitral valve pro- lapse and risk of ventricular dysrhythmias and death. J Cardiovasc Electrophysiol. 2016;27:463 8. S10.6-6. Basso C, Perazzolo MM, Rizzo S, et al. Arrhythmic mitral valve pro- lapse and sudden cardiac death. Circulation. 2015;132:556 66. S10.6-7. Sriram CS, Syed FF, Ferguson ME, et al. 